A randomised controlled trial of meloxicam, a Cox-2 inhibitor, to prevent hepatocellular carcinoma recurrence after initial curative treatment

BACKGROUND: Because the recurrence rate of hepatocellular carcinoma (HCC) is high, even after curative treatments such as hepatic resection and microwave ablation, chemopreventive agents that can effectively suppress HCC recurrence are required. Cyclooxygenase-2 (Cox-2) was recently found to be over...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hepatol Int
Hauptverfasser: Takami, Yuko, Eguchi, Susumu, Tateishi, Masaki, Ryu, Tomoki, Mikagi, Kazuhiro, Wada, Yoshiyuki, Saitsu, Hideki
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer India 2016
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5003903/
https://ncbi.nlm.nih.gov/pubmed/26846471
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12072-016-9704-y
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge